Bacterial Immune Protein Activates by Encircling Phage Rings

Bacteria have evolved a sophisticated arsenal of mechanisms to defend against viruses, scientifically termed bacteriophages. While numerous anti-phage systems assemble into massive, multi-protein complexes, the precise molecular signals that govern this assembly during an active infection have historically remained obscure. This research elucidates that a bacterial immune protein designated RAZR (ring-activated zinc-finger RNase) achieves activation by constructing a colossal 24-unit ring around circular architectures generated by two distinct classes of phage proteins: a putative recombinase and a portal protein. These formidable, multi-layered complexes empower RAZR to cleave RNA with broad specificity, effectively halting protein synthesis and arresting phage replication. The capacity of RAZR to be activated by unrelated phage proteins that assemble into rings of comparable dimensions suggests that it recognizes a specific geometric feature rather than a discrete protein sequence. Because host bacteria do not synthesize analogous large ring structures, RAZR likely remains quiescent until an infection event occurs, thereby preventing detrimental self-harm. This infection-triggered assembly mirrors the pathogen-induced oligomerization observed in eukaryotic immune systems, revealing a shared strategic principle across the tree of life.

A recurring strategy within the innate immune systems of complex organisms involves the assembly of large, multi-protein complexes. When pattern recognition receptors detect specific molecular signatures characteristic of a pathogen, they can recruit additional immune proteins to form massive structures that initiate potent defensive responses. This capacity for oligomerization facilitates significant signal amplification and creates an efficient, switch-like response to an invader.

Bacteria similarly encode diverse innate immune systems to safeguard against phages, yet the specific mechanisms of detection and activation often remain enigmatic. Certain bacterial defenses oligomerize only after binding to a small signaling molecule, but the trigger for the initial production of that signal during a phage attack remains unclear. Recent investigations indicate that some bacterial systems directly sense phage proteins. For instance, antiviral STAND proteins bind to phage proteins and subsequently form active four-unit complexes, at least within laboratory settings. Structural analyses reveal that many anti-phage systems form very large oligomers independently, though the specific phage-derived signal each one detects is typically unknown.

This investigation focused on an anti-phage system initially identified through metagenomic analysis and designated PD-T7-4, which researchers later renamed RAZR. Homologs of RAZR are distributed across numerous bacterial groups. The protein comprises an N-terminal zinc-finger domain (ZFD) and a C-terminal domain (DUF4145) that represents a variant of a HEPN ribonuclease (RNase). HEPN domains typically function in pairs, with two monomers associating to form a single, precise RNA-cutting site. RAZR operates via an abortive infection mechanism: an infected cell dies or ceases growth, thereby protecting the broader bacterial population by containing the viral threat. How RAZR is switched on during infection and how it restricts phage replication were previously open questions.

The study examined a RAZR system derived from Escherichia coli. As anticipated, RAZR provided robust defense against several phages, including T3, T7, SECΦ18, and SECΦ27. Bioinformatic analysis predicted the structure of RAZR, confirming the presence of the ZFD and a HEPN-like domain. Mutating conserved catalytic residues (R146 and H154) within this HEPN domain eliminated RAZR's defensive capability, confirming its role as an active RNase.

Interestingly, overproducing RAZR was not toxic to bacterial cells, suggesting it requires activation by a specific phage factor. To identify this trigger, researchers isolated mutant versions of phage SECΦ27 that could evade RAZR defense. All escape mutants possessed single amino acid changes in a phage protein named Gp77. Gp77 is conserved among related phages and exhibits structural similarity to a protein in another phage that assists in circularizing the viral genome upon entry, suggesting it is essential. Indeed, a SECΦ27 variant lacking the gene for Gp77 could not infect cells unless Gp77 was provided in trans.

Co-producing normal Gp77 with RAZR rendered RAZR toxic to bacterial cells even in the absence of a phage, whereas mutant Gp77 proteins from the escape phages did not. This demonstrated that Gp77 alone was sufficient to activate RAZR, likely through a direct interaction confirmed by co-precipitation experiments.

RAZR also defended against phages T3, T7, and SECΦ18. These phages are not closely related to SECΦ27 and lack a Gp77 equivalent. Escape mutants for these phages were subsequently isolated. In each instance, the mutations were located in the gene for the phage's portal protein, or a protein structurally homologous to it. Portal proteins are essential, conserved components that form the channel for viral DNA entry and packaging. Co-producing these portal proteins with RAZR also triggered toxicity, indicating they too are sufficient activators. The portal proteins also co-precipitated with RAZR, suggesting direct binding. Notably, SECΦ27 possesses its own portal protein, but it did not activate RAZR, consistent with Gp77 being its specific trigger.

These results demonstrate that RAZR can be activated by multiple, structurally unrelated proteins from different phages: Gp77 (a putative recombinase) from SECΦ27, and the portal proteins from T3, T7, and SECΦ18.

To understand the activation mechanism, scientists purified RAZR and its activator Gp77. Both proteins independently formed large oligomers. When mixed, they assembled into an even larger complex of approximately 1.4 megadaltons. Cryo-electron microscopy (cryo-EM) analysis provided a visual explanation.

Gp77 alone formed a symmetric, 24-unit ring. RAZR alone formed linear oligomers of variable length. However, when RAZR and Gp77 were combined—either by mixing purified proteins or by co-expressing them in cells—they formed a striking, three-layered ring structure approximately 270 angstroms in diameter.

The high-resolution cryo-EM structure revealed the complex's architecture. The inner ring consists of 24 copies of Gp77. Surrounding this is a central ring made of 12 dimers of RAZR's zinc-finger domains. These ZFDs face inward to contact the Gp77 ring. The HEPN RNase domains of RAZR extend outward, forming a third, outer ring. Experiments with antibodies tagged to RAZR confirmed this orientation. In this assembled state, the HEPN domains are positioned in a dimeric arrangement that creates a functional RNase active site. Comparison with predicted models suggests that binding to the Gp77 ring causes RAZR's linear oligomers to bend into a curved conformation, which may be crucial for activating the RNase.

Since RAZR also recognizes phage portal proteins, the team analyzed its complex with the T7 portal protein, Gp8. Portal proteins like Gp8 naturally form 12-unit rings. Cryo-EM 2D classes showed that RAZR and Gp8 also formed a multi-layered, ring-shaped complex. Although a high-resolution structure was not obtained, the data support a model where RAZR assembles around the portal ring, similar to its assembly around Gp77. A key observation is that the Gp77 ring and the Gp8 portal ring have nearly identical diameters (approximately 170 Å). This indicates that RAZR activation is triggered by recognizing protein rings of a characteristic size, allowing it to sense geometrically similar but structurally distinct phage proteins.

The researchers next explored how RAZR's zinc-finger domain binds to Gp77. In the structure, a dimer of RAZR ZFDs interacts with the Gp77 ring. Modeling suggested specific residues (such as R29, Y31, R35, T41, and E43 on RAZR) are critical for this interface, potentially forming salt bridges and hydrogen bonds with Gp77.

Mutating these RAZR residues to alanine or other amino acids reduced or abolished RAZR activation by Gp77 and weakened defense against phage SECΦ27. These mutations also impaired the physical interaction between RAZR and Gp77 in co-precipitation assays. Interestingly, some mutations (Y31A, E43R, T41D) that blocked defense against SECΦ27 (which uses Gp77) still allowed defense against SECΦ18 (which uses a portal protein). Other mutations (R29A, R29E, R35E) blocked defense against both phages. This implies the binding interfaces for Gp77 and the portal protein overlap but also involve distinct contacts.

This work elucidates a sophisticated bacterial immune strategy. The RAZR protein remains inactive as linear oligomers until a phage infection provides a specific geometric trigger: a large protein ring. By assembling around these rings—formed by essential phage proteins like recombinases or portal complexes—RAZR undergoes a structural transition that activates its potent, non-specific RNase activity. This halts cellular translation and sacrifices the infected cell to protect the population. The system's specificity for phage-derived rings of a precise diameter likely prevents accidental activation by the host's own proteins. This discovery of geometry-sensing activation parallels mechanisms in eukaryotic immunity, highlighting a convergent evolutionary solution for pathogen detection.